Long non-coding RNAs in the doxorubicin resistance of cancer cells-Reference-Cited by-同舟云学术

Long non-coding RNAs in the doxorubicin resistance of cancer cells

Published:2021-06 Issue: Volume:508 Page:104-114
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Ashrafizaveh Saeed,Ashrafizadeh Milad,Zarrabi Ali,Husmandi Kiavash,Zabolian Amirhossein,Shahinozzaman Md,Aref Amir Reza,Hamblin Michael R.,Nabavi Noushin,Crea Francesco,Wang Yuzhuo,Ahn Kwang Seok

Funder

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference152 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA A Cancer J. Clin.,2018

2. Ursodeoxycholic acid and cancer: from chemoprevention to chemotherapy;Goossens;Pharmacol. Ther.,2019

3. YY1 regulates cancer cell immune resistance by modulating PD-L1 expression;Hays;Drug Resist. Updates,2019

4. Determinants and clinical implications of chromosomal instability in cancer;Sansregret;Nat. Rev. Clin. Oncol.,2018

5. LncRNA KCNQ1OT1 contributes to the progression and chemoresistance in acute myeloid leukemia by modulating Tspan3 through suppressing miR-193a-3p;Sun;Life Sci.,2020

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Targeting Strategies in Pancreatic Cancer: The Role of Tumor Microenvironment;Cancers;2024-08-19

2. One-pot preparation of quercetin-doxorubicin dual-drug co-loaded nanosystem for multimodal treatment of tumors;Journal of Drug Delivery Science and Technology;2024-08

3. GAS5 lncRNA: A biomarker and therapeutic target in breast cancer;Pathology - Research and Practice;2024-08

4. LINC01605 promotes malignant phenotypes of cervical cancer via miR-149-3p/WNT7B axis;Gene;2024-08

5. Hyaluronic acid nanoparticles for targeted oral delivery of doxorubicin: Lymphatic transport and CD44 engagement;International Journal of Biological Macromolecules;2024-07